Improving the safety of stem-cell-derived beta cell transplantation with an inducible safety switch

被引：0
作者：
Chu, Simon N. [1 ,4 ,5 ]
Amirruddin, N. Shabrina [2 ,3 ,4 ,5 ]
Sharma, Devesh K. [1 ,5 ]
Sierra, Isabel C. [2 ,3 ,4 ,5 ]
Stock, Peter G. [1 ]
Sneddon, Julie B. [2 ,3 ,4 ,5 ]
Cromer, M. Kyle [1 ,5 ,6 ]
机构：
[1] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Anat, San Francisco, CA USA
[4] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA USA
[5] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med, San Francisco, CA USA
[6] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA USA
来源：
TRANSPLANTATION | 2023年 / 107卷 / 10期
关键词：
D O I：
10.1097/01.tp.0000994680.51057.c0
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
410.8
引用
收藏
页码：165 / 166
页数：2
相关论文
共 50 条
[41]   Safety of pembrolizumab after allogeneic haematopoietic stem cell transplantation [J].
Kwong, Yok-Lam .
ANNALS OF HEMATOLOGY, 2016, 95 (07) :1191-1192
[42]   Efficacy and Safety of Aprepitant in Allogeneic Hematopoietic Stem Cell Transplantation [J].
Uchida, Mayako ;
Kato, Koji ;
Ikesue, Hiroaki ;
Ichinose, Kimiko ;
Hiraiwa, Hiromi ;
Sakurai, Asako ;
Muta, Tsuyoshi ;
Takenaka, Katsuto ;
Iwasaki, Hiromi ;
Miyamoto, Toshihiro ;
Teshima, Takanori ;
Shiratsuchi, Motoaki ;
Suetsugu, Kimitaka ;
Nagata, Kenichiro ;
Egashira, Nobuaki ;
Akashi, Koichi ;
Oishi, Ryozo .
PHARMACOTHERAPY, 2013, 33 (09) :893-901
[43]   Safety of vaccines in a cohort of allogeneic stem cell transplantation recipients [J].
Targhetta, Clara ;
Simula, Maria Pina ;
Depau, Cristina ;
Vacca, Adriana ;
Piras, Eugenia ;
Durzu, Tania ;
Rojas, Rodrigo ;
Serreli, Valentina ;
Cardani, Sara ;
La Nasa, Giorgio .
BONE MARROW TRANSPLANTATION, 2019, 54 :260-260
[44]   A metabolic safety switch for cell therapy [J].
Willson, Joseph .
NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (09) :586-586
[45]   A metabolic safety switch for cell therapy [J].
Joseph Willson .
Nature Reviews Drug Discovery, 2020, 19 (9) :586-586
[46]   Highly sensitive biosafety model for stem-cell-derived grafts [J].
Lawrenz, B ;
Schiller, H ;
Willbold, E ;
Ruediger, M ;
Muhs, A ;
Esser, S .
CYTOTHERAPY, 2004, 6 (03) :212-222
[47]   Stem-Cell-Derived Astrocytes Divulge Secrets of Mutant GFAP [J].
Sofroniew, Michael V. .
CELL STEM CELL, 2018, 23 (05) :630-631
[48]   Unlocking the potential of stem-cell-derived ‘synthetic’ embryo models [J].
Fu, Yanqiong ;
Fan, Qin ;
Wu, Yanru ;
Bao, Min .
Trends in Biotechnology, 2025, 43 (08) :1849-1863
[49]   Can stem-cell-derived models revolutionize drug discovery? [J].
Landgren, Henrik ;
Sartipy, Peter .
EXPERT OPINION ON DRUG DISCOVERY, 2014, 9 (01) :9-13
[50]   MK - A PLURIPOTENTIAL EMBRYONIC STEM-CELL-DERIVED NEUROREGULATORY FACTOR [J].
NURCOMBE, V ;
FRASER, N ;
HERLAAR, E ;
HEATH, JK .
DEVELOPMENT, 1992, 116 (04) :1175-1183
12345